Personalized medicine
This function is exclusive for Premium subscribers
ARTICLES (1)
iLoF: Accelerating access to personalized medicine, from a drop of blood
Backed by Microsoft’s venture fund M12, Mayfield and Melinda Gates’s Pivotal Ventures, iLoF focuses on painless screening to facilitate disease detection, forecasting and drug development, from Alzheimer’s to Covid-19